The scale of Jiangsu Lianhuan Pharmaceutical Group Co., Ltd.

Jiangsu Lianhuan Pharmaceutical Group has strong pharmaceutical R&D strength, and has established provincial medical technology center, provincial postdoctoral science and technology innovation center, provincial cardiovascular series drug engineering technology research center, Jiangsu Lianchuang pharmaceutical technology company, steroid drug research institute, Yangzhou Lianhuan pharmaceutical technology development company and other R&D institutions. It has established good joint development relations with China Pharmaceutical University, Nanjing University, Nanjing University of Technology, Shenyang Pharmaceutical University, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences and other institutions and scientific research institutes, and has successively contributed to the society the first-class national new drugs, namely April, April tablets (Liu Chuan), the second-class new drugs, Terfenadine tablets (Mindy), Ebastine and Ebastine tablets (Sudi). Four new drugs, such as felodipine, and more than 20 national new drugs, such as felodipine tablets (diclofenac), Danazol Suppository, Terfenadine Granules, Omeprazole Enteric-coated Tablets, Cetirizine Hydrochloride and Cetirizine Hydrochloride Tablets (in duplicate), Simvastatin and Simvastatin Tablets (Sign), tropisetron hydrochloride and Tropisetron Hydrochloride Injection (Proline).